MARKER THERAPEUTICS, INC. Other Comprehensive Income (Loss), Net of Tax
MARKER THERAPEUTICS, INC. (MRKR) reported Other Comprehensive Income (Loss), Net of Tax of $28.50 million for the 3-month period ending 2015-09-30, per its 10-Q/A filed 2016-04-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2016-04-14
- MARKER THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2015-09-30 was $28.50M.
- MARKER THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2015-06-30 was -$60.22M, a 8080.72% decline year-over-year.
- MARKER THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2015-03-31 was -$700.72K.
- MARKER THERAPEUTICS, INC. other comprehensive income (loss), net of tax for the quarter ending 2014-09-30 was -$1.56M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month |
|---|---|---|---|
| 2015-09-30 | $28.50M 10-Q/A · filed 2016-04-14 | -$31.71M derived: sum of 2 quarters · filed 2016-04-14 | -$32.41M 10-Q/A · filed 2016-04-14 |
| 2015-06-30 | -$60.22M 10-Q/A · filed 2016-04-14 | -$60.92M 10-Q/A · filed 2016-04-14 | |
| 2015-03-31 | -$700.72K 10-Q/A · filed 2016-04-14 | ||
| 2014-09-30 | -$1.56M 10-Q/A · filed 2016-04-14 | -$810.34K derived: sum of 2 quarters · filed 2016-04-14 | -$30.14M 10-Q/A · filed 2016-04-14 |
| 2014-06-30 | $754.52K 10-Q/A · filed 2016-04-14 | -$28.95M 10-Q/A · filed 2016-04-14 | |
| 2014-03-31 | -$29.71M 10-Q/A · filed 2016-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |